Approval · Notice of Compliance 20860 · 2018
ENTROPHEN: Notice of Compliance 20860
Issued May 15, 2018
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 20860
- Date
- May 15, 2018
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Other
- Reason
- Alternate manufacturing fite for the finished product
- Canadian reference product
- COATED ASPIRIN DAILY LOW DOSE 81 MG (Bayer Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ENTROPHEN | Not yet assigned | — |
Medicinal ingredients
- ACETYLSALICYLIC ACID 81 MG per TAB